Skip to main content
OpenTrials

Clinical trial condition

Atypical Hemolytic Uremic Syndrome

Explore clinical trials studying Atypical Hemolytic Uremic Syndrome. Study availability and eligibility vary by location and protocol.

17 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Atypical Hemolytic Uremic Syndrome trial results

Recruiting

Evaluate Long-term Safety, Tolerability and Efficacy of Iptacopan in Study Participants With aHUS

NCT05795140

Conditions
Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +18 more
Locations
  • Novartis Investigative Site São Paulo, Brazil
  • Novartis Investigative Site Rio de Janeiro, Brazil
  • Novartis Investigative Site Beijing, China
  • Novartis Investigative Site Ostrava, Poruba, Czechia
View Trial Details
Recruiting

Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypical Hemolytic Uremic Syndrome (aHUS)

NCT05935215

Conditions
Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +14 more
Locations
  • Novartis Investigative Site Nanjing, Jiangsu, China
  • Novartis Investigative Site Beijing, China
  • Novartis Investigative Site Beijing, China
  • Novartis Investigative Site Shanghai, China
View all 31 locations
View Trial Details
Completed

Efficacy and Safety of Iptacopan (LNP023) in Adult Patients With Atypical Hemolytic Uremic Syndrome Naive to Complement Inhibitor Therapy

NCT04889430

Conditions
Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +14 more
Locations
  • USC Norris Cancer Center Los Angeles, California, United States
  • Univ of California at Los Angeles Los Angeles, California, United States
  • Univ Cali Irvine ALS Neuromuscular Orange, California, United States
  • Univ of California at Sacramento Sacramento, California, United States
View all 36 locations
View Trial Details
Completed

Eculizumab to Treat Thrombotic Microangiopathy/Atypical Hemolytic Uremic Syndrome -Associated Multiple Organ Dysfunction Syndrome in Hematopoietic Stem Cell Transplant Recipients

NCT03518203

Conditions
Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +19 more
Locations
  • Children's Hospital Los Angeles (CHLA) Los Angeles, California, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
  • Children's Hospital of Philadelphia (CHOP) Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Observational Study of Elizaria® in aHUS Patients

NCT04749810

Conditions
Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +21 more
Locations
  • Federal State Budgetary Educational Institution of Higher Education "Kazan State Medical University" of the Ministry of Health of the Russian Federation Kazan', Russia
  • Regional State Budgetary Healthcare Institution "Krasnoyarsk' Regional Clinical Center for Maternity and Childhood Protection" Krasnoyarsk, Russia
  • State budgetary healthcare institution of the city of Moscow "Children's City Clinical Hospital of St. Vladimir of the Healthcare Department of the City of Moscow" Moscow, Russia
  • Federal State Autonomous Educational Institution of Higher Education "First Moscow State Medical University n.a. I.M. Sechenov" of the Ministry of Health of the Russian Federation Moscow, Russia
View Trial Details

Related conditions